Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.

Annals of hematology - 1 May 2015

Ammatuna Emanuele, Eefting Matthias, van Lom Kirsten, Kavelaars François G, Kavelaars François F, Valk Peter J M, Touw Ivo P

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to Janus Kinases
Share to Mutation
Share to Nitriles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nuclear Proteins

Share to Pyrazoles

Share to Pyrimidines

Share to Receptors, Colony-Stimulating Factor

Source

Identifiers

PMID: 25491280
DOI: 10.1007/s00277-014-2272-0

Genes

SETBP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.PMID 25491280Read ↗

Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib.Semantic proximity Read ↗

Atypical Chronic Myeloid Leukemia: Where Are We Now?Semantic proximity Read ↗

Genetic Response of Chronic Neutrophilic Leukemia With CSF3R T618I, SETBP1, and ASXL1 Mutations After Decitabine Therapy.Semantic proximity Read ↗

Atypical chronic myeloid leukemia: a rare entity with management challenges.Semantic proximity Read ↗

Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.Semantic proximity Read ↗

Changes in allele frequencies of CSF3R and SETBP1 mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinibSemantic proximity Read ↗

Current and evolving understanding of atypical chronic myeloid leukemia.Semantic proximity Read ↗

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.Semantic proximity Read ↗

Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.Semantic proximity Read ↗

Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia.Semantic proximity Read ↗

Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasmSemantic proximity Read ↗

Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.